NCT04421625 2025-12-30
PAPESCO-19
Institut Cancerologie de l'Ouest
Phase NA Completed
Clinical Trials
5 trialsNCT03981809 2023-08-22
PainsCan
Universitaire Ziekenhuizen KU Leuven
Completed
NCT03067389 2019-01-15
Combined Breast Cancer Risk Study
Myriad Genetic Laboratories, Inc.
Completed
NCT03081455 2017-08-08
Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes
Myriad Genetic Laboratories, Inc.
Completed
NCT00633620 2008-03-12
BECOP-2
Charite University, Berlin, Germany
Phase NA Completed